GBAIS arkistot | MVision AI

Deep learning to generate synthetic CT Images from MR for Radiotherapy treatment planning

The generation of synthetic images has greatly advanced in recent years due to the progress of artificial intelligence. Some of the applications have recently been…

NCCC Evaluation of MVision AI contouring software

S Warren, N Richmond MVision AI software has been under evaluation at NCCC (Newcastle upon Tyne Hospitals NHS Foundation Trust) since 28 February 2022* in…

What guidelines do clinicians follow for breast contouring?

According to the NHS, breast cancer is the most common type of cancer in the UK. Roughly 1 in 8 women are diagnosed with breast…

2021 MVision AI Re-cap: The Year of GCAIS™

2021 is an innovative and foundational year for MVision AI. We are proud of what we have accomplished so far and super excited about what…

Medron Medical Systems Inc. is Introducing MVision’s Groundbreaking Auto-Segmentation Solution to Canada

Helsinki – December 9, 2021 – MVision AI, the leading software service provider of guideline-based AI segmentation, GBAIS™, for radiotherapy treatment planning, declares a new…

Important Methods for Radiotherapy Treatment

60-70% of cancer patients receive some type of radiation therapy. For some cancers, radiation therapy alone is an effective treatment. The purpose of radiotherapy is…

SBRT as an Effective Modality for Lung Cancer Treatment

Stereotactic body radiotherapy (SBRT), or stereotactic ablative body radiotherapy (SABR), is an innovative radiation therapy technique. The technique uses special equipment to precisely deliver a…

YourRad AB is Providing MVision’s AI-Powered Segmentation Service to Nordic Cancer Hospitals

Helsinki – 5th of November, 2021 – MVision AI, the pioneer of SaaS radiotherapy treatment planning optimization, announces their distribution partnership YourRad AB, the prime…